Neuren Pharmaceuticals | NEU - Operating Expenses


Neuren Pharmaceuticals reported AUD25.23M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 952K 60K Jun/2026
Avita Medical AUD 28.56M 534K Jun/2026
Clinuvel Pharmaceuticals AUD 23.42M 6.49M Dec/2025
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Genetic Signatures AUD 17.52M 9.22M Dec/2025
Ionis Pharmaceuticals USD 373M 2.76M Sep/2026
Medical Developments International AUD 21.61M 11.59M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Organon & Co USD 1.19B 187M Sep/2026
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Tectonic Therapeutic USD 24.22M 3.08M Jun/2026
Telix Pharmaceuticals AUD 430.99M 25.59M Jun/2026
Viatris USD 3.49B 189.1M Sep/2026
Xeris Pharmaceuticals USD 86.93M 11.72M Jun/2026